tradmap

GEHC Earnings GE HealthCare

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
$0 $2 $5 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $10B $21B 2021 2022 2023 2024 2025
Revenue
Net income (annual)
$0 $1B $2B 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
$0 $1 $2 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
EPS
Revenue (quarterly)
$0 $3B $6B Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue
Net income (quarterly)
$0 $361M $721M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Net income

Reported EPS history

1–24 of 24
Q3 20262026-09-301.362026-10-2810-Q
Q2 20262026-06-301.242026-07-2910-Q
Q1 20262026-03-310.852026-04-2910-Q
Q4 2025 (derived)2025-12-311.282026-02-0410-K
FY 20252025-12-314.552026-02-0410-K
Q3 20252025-09-300.982025-10-2910-Q
Q2 20252025-06-301.062025-07-3010-Q
Q1 20252025-03-311.232025-04-3010-Q
Q4 2024 (derived)2024-12-311.582025-02-1310-K
FY 20242024-12-314.342025-02-1310-K
Q3 20242024-09-301.022024-10-3010-Q
Q2 20242024-06-300.932024-07-3110-Q
Q1 20242024-03-310.812024-04-3010-Q
Q4 2023 (derived)2023-12-310.892024-02-0610-K
FY 20232023-12-313.032024-02-0610-K
Q3 20232023-09-300.822023-10-3110-Q
Q2 20232023-06-300.912023-07-2510-Q
Q1 20232023-03-310.412023-04-2510-Q
Q4 2022 (derived)2022-12-311.22——
FY 20222022-12-314.22——
Q3 20222022-09-301.07——
Q2 20222022-06-301.07——
Q1 20222022-03-310.86——
FY 20212021-12-314.95——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.